---
$id: https://graph.org.ai/products/commodity/51392226
$type: Product
source: UNSPSC
code: "51392226"
title: "Metizoline hydrochloride"
class: "51392200"
classTitle: "Sympathomimetic or adrenergic imidazoles"
family: "51390000"
familyTitle: "Sympathomimetic or adrenergic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Metizoline hydrochloride

**UNSPSC Code**: 51392226
**Class**: [Sympathomimetic or adrenergic imidazoles](Sympathomimetic or adrenergic imidazoles.mdx)
**Family**: [Sympathomimetic or adrenergic drugs](../Sympathomimetic or adrenergic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an adrenergic agonist with the molecular formula C13H14N2S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PU364U720Z, chemically known as 4,5-dihydro-2-((2-methylbenzo(b)thien-3-yl)methyl)-1h-imidazole monohydrochloride but more generally known as metizoline hydrochloride, which bears US NIH Compound Identifier 68629. Most nations, for tariff and trade purposes, schedule metizoline hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, METIZOLINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Metizoline hydrochloride bears US NLM identifiers UMLS ID C2983811 and NCI Concept Code C90632. SMILES: CC1C(C2CCCCC2S1)CC3=NCCN3.CL.

